PeptiDream Inc (PPTDF)
13.11
+3.61
(+38.00%)
USD |
OTCM |
Apr 30, 16:00
PeptiDream Profit Margin (Quarterly): -8.20% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.20% |
| September 30, 2023 | 32.55% |
| June 30, 2023 | -10.76% |
| March 31, 2023 | -5.01% |
| December 31, 2022 | 49.48% |
| September 30, 2022 | 15.29% |
| June 30, 2022 | -6.58% |
| March 31, 2022 | -197.7% |
| December 31, 2021 | 6.08% |
| September 30, 2021 | 50.67% |
| June 30, 2021 | -4.92% |
| March 31, 2021 | -15.01% |
| December 31, 2020 | 47.77% |
| September 30, 2020 | -26.09% |
| June 30, 2020 | 45.36% |
| March 31, 2020 | -86.52% |
| September 30, 2019 | -46.92% |
| June 30, 2019 | 48.37% |
| March 31, 2019 | 9.55% |
| December 31, 2018 | 39.29% |
| September 30, 2018 | 5.99% |
| Date | Value |
|---|---|
| June 30, 2018 | 59.86% |
| March 31, 2018 | -132.6% |
| December 31, 2017 | 15.55% |
| September 30, 2017 | -379.1% |
| June 30, 2017 | 49.63% |
| March 31, 2017 | -73.38% |
| December 31, 2016 | 19.38% |
| September 30, 2016 | 35.07% |
| June 30, 2016 | 36.70% |
| March 31, 2016 | 44.35% |
| December 31, 2015 | 32.41% |
| September 30, 2015 | 9.65% |
| June 30, 2015 | 51.51% |
| March 31, 2015 | -28.62% |
| December 31, 2014 | 28.03% |
| September 30, 2014 | -15.09% |
| June 30, 2014 | 18.44% |
| March 31, 2014 | -17.08% |
| December 31, 2013 | 41.09% |
| September 30, 2013 | 5.26% |
| June 30, 2013 | 1.84% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-197.7%
Minimum
Mar 2022
50.67%
Maximum
Sep 2021
-6.23%
Average
-4.97%
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 9.51% |
| Nxera Pharma Co Ltd | -2.85% |
| Stemcell Holdings Inc | -- |
| Healios KK | -24.73K% |
| AnGes Inc | -5.24K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.41% |
| Return on Assets | 4.57% |
| Return on Invested Capital | 5.29% |
| Gross Profit Margin (Quarterly) | 48.45% |
| Operating Margin (Quarterly) | 0.33% |
| Return on Net Operating Assets | 7.31% |